Istituto Oncologico Veneto
Padova, Veneto 35128
1 studies enrolling now · 3 studies all time
What they study most
Glioma, H3 K27M, Solid Tumors Harboring NTRK Fusion, Urothelial Carcinoma
Studies at this site
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) — Recruiting now
- A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors — Completed
- Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma — Completed